We are live on ! Find out more
Lazard Asset Management

Lazard Asset Management Portfolio holdings

AUM $60.8B
1-Year Est. Return 22.47%
This Fund
S&P 500
This Quarter Est. Return
+0.1%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$68.4B
AUM Growth
-$6.42B
Cap. Flow
-$9.95B
Cap. Flow %
-14.55%
Top 10 Hldgs %
25.74%
Holding
2,605
New
281
Increased
825
Reduced
894
Closed
234

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$433M
2
MRK icon
Merck
MRK
+$286M
3
J icon
Jacobs Solutions
J
+$265M
4
EFX icon
Equifax
EFX
+$253M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$240M

Sector Composition

Rank Sector Weight
1 Technology 26.04%
2 Financials 14.64%
3 Healthcare 12%
4 Industrials 10.54%
5 Consumer Discretionary 9.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HFFG icon
2201
HF Foods Group
HFFG
$79.7M
-498
Closed -$1K
HGV icon
2202
Hilton Grand Vacations
HGV
$3.52B
-7,249
Closed -$263K
HOOK
2203
DELISTED
HOOKIPA Pharma
HOOK
-218
Closed
HP icon
2204
Helmerich & Payne
HP
$3.41B
-4,025
Closed -$122K
HPP
2205
Hudson Pacific Properties
HPP
$786M
$0 ﹤0.01%
+12
New +$328
HQY icon
2206
HealthEquity
HQY
$8.72B
-11,156
Closed -$913K
STRR
2207
Star Equity Holdings
STRR
$39.6M
$0 ﹤0.01%
+56
New +$826
HUYA
2208
Huya Inc
HUYA
$572M
-566
Closed -$2K
IBCP icon
2209
Independent Bank Corp
IBCP
$793M
-2,918
Closed -$97K
IBKR icon
2210
Interactive Brokers
IBKR
$39.1B
$0 ﹤0.01%
12
IBRX icon
2211
ImmunityBio
IBRX
$7.49B
$0 ﹤0.01%
98
IDA icon
2212
Idacorp
IDA
$8.32B
-3,075
Closed -$317K
IIIN icon
2213
Insteel Industries
IIIN
$602M
-1,442
Closed -$44K
IMKTA icon
2214
Ingles Markets
IMKTA
$1.74B
-1,047
Closed -$78K
INFA
2215
DELISTED
Informatica
INFA
-31,737
Closed -$802K
INFU icon
2216
InfuSystem Holdings
INFU
$186M
-181
Closed -$1K
INN
2217
Summit Hotel Properties
INN
$749M
$0 ﹤0.01%
+70
New +$460
INOD icon
2218
Innodata
INOD
$2.07B
$0 ﹤0.01%
18
-958
-98% -$30.2K
INTT icon
2219
inTEST
INTT
$167M
-168
Closed -$1K
IOT icon
2220
Samsara
IOT
$21.6B
$0 ﹤0.01%
+15
New +$738
IOVA icon
2221
Iovance Biotherapeutics
IOVA
$1.95B
$0 ﹤0.01%
65
ITOS
2222
DELISTED
iTeos Therapeutics
ITOS
-57,743
Closed -$589K
JBI icon
2223
Janus International
JBI
$739M
-149,303
Closed -$1.51M
JCSE icon
2224
JE Cleantech Holdings
JCSE
$7.43M
$0 ﹤0.01%
+524
New +$717
JILL icon
2225
J. Jill
JILL
$277M
-41
Closed -$1K

Similar funds

Lazard Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Lazard Asset Management held 2,605 positions worth $68.4B, down 8.6% from $74.8B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Lazard Asset Management withdrew a net $9.95B in Q4 2024, closing 234 positions and reducing 894 holdings. Its most notable exit was Atlantica Sustainable Infrastructure plc Ordinary Shares, an estimated $210M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Lazard Asset Management opened a new position in Vaxcyte worth $39.8M.

  • Lazard Asset Management's largest Q4 2024 buy was Vaxcyte: 486,764 shares worth $39.8M.
  • Lazard Asset Management added most to Eli Lilly in Q4 2024, an estimated $433M increase.
  • Lazard Asset Management's biggest Q4 2024 reduction was Microsoft, cutting an estimated $710M.
  • Lazard Asset Management fully exited Atlantica Sustainable Infrastructure plc Ordinary Shares in Q4 2024, selling an estimated $210M.
  • Lazard Asset Management's ten largest holdings make up 26% of its $68.4B portfolio in Q4 2024.
  • Lazard Asset Management opened 281 new positions and closed 234 in Q4 2024.
  • Lazard Asset Management's portfolio value fell 8.6% quarter-over-quarter to $68.4B.

Based on Lazard Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.